Post-approval studies (Phase 4)Study completedNCT00305903
What this trial is testing
Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Novartis 150